Others have reported an overexpression of ADAM-12 in liver carcinomas (Le Pabic et al, 2003), and its levels in urine from patients have been correlated with survival in breast cancer (Roy et al, 2004). Here, ADAM12 is linked to hepatocellular carcinoma.